Myoung Hee Kang

Antibody-Mediated Therapies in Urothelial Carcinoma: A Critical Narrative Review

Urothelial carcinoma (UCC) remains a clinical challenge due to its high recurrence rate and aggressive advanced-stage behavior. Driven by a high tumor mutational burden and the consistent overexpression of surface antigens, including Nectin-4, Trop-2, and HER2, UCC has become a p...